No Result
View All Result
  • Login
Monday, August 17, 2026
FeeOnlyNews.com
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading
No Result
View All Result
FeeOnlyNews.com
No Result
View All Result
Home Markets

6 Ways to Beat the TV Drug Ads That Are Working on You

by FeeOnlyNews.com
2 months ago
in Markets
Reading Time: 4 mins read
A A
0
6 Ways to Beat the TV Drug Ads That Are Working on You
Share on FacebookShare on TwitterShare on LInkedIn


You know the ad. A couple strolls a beach at sunset, a dog bounds through a meadow, somebody finally hugs their grandkid — all while a soothing voice rattles off side effects that somehow include death.

Then comes the kicker: “Ask your doctor about [drug name].”

Here’s something most people don’t realize. The U.S. and New Zealand are the only two countries on the planet that let drug companies pitch prescription medications straight to you. Everybody else decided it was a bad idea.

So why do these ads keep running? Because they work. Spectacularly.

My wife, Sara, is a nurse practitioner. She’ll tell you patients walk in asking for drugs by name all the time — drugs they saw on TV the night before.

The research backs her up. Researchers at University of Southern California’s Schaeffer Center found that drug use jumped about 6% in areas blanketed with more ads. Drugmakers spent $550 million on these commercials in 1996. By 2020, that number topped $6.5 billion.

The government finally noticed. In September 2025, the Trump administration ordered a crackdown, and the FDA fired off about 100 cease-and-desist letters — plus thousands of warnings — to companies running misleading ads. Health and Human Services Secretary Robert F. Kennedy Jr. put it bluntly: “Pharmaceutical ads hooked this country on prescription drugs.”

But these ads aren’t going anywhere soon. So the smartest move is learning to watch them without getting played. I spent a decade on Wall Street watching pros separate people from their money, so trust me — a polished sales pitch is still a sales pitch. Here’s how to win.

1. Remember the ad’s only job is to sell you something

A drug commercial isn’t a public service announcement. It’s a sales pitch with a multibillion-dollar budget.

The goal isn’t to inform you. It’s to get you into a doctor’s office asking for one specific product by name. Former FDA Commissioner Marty Makary has said drugmakers spend up to a quarter of their budgets on advertising.

Once you see the ad as a sales tool instead of medical advice, it loses a lot of its grip.

2. Pay attention to the part they rush through

Notice how the happy images roll while the voice lists the scary stuff? That’s no accident. The law forces companies to disclose a drug’s major risks, so they bury those warnings under beach scenes and golden retrievers.

Flip it around. Mute the puppies and actually listen to the side effects.

That recital is the one part of the ad they’re legally required to get right. An FDA review last year found that while every pharmaceutical social media post touted a drug’s benefits, only about a third bothered to mention the possible harms.

3. Ask the question the ad hopes you won’t

Every one of these commercials is built to make you want the drug. Almost none of them ask whether you need it.

That matters. The USC researchers found that people who started a medication because of an ad were, on average, less likely to stick with it — a hint that some of those prescriptions weren’t necessary to begin with.

The White House made the same point in its 2025 order: These ads can push people toward pills and away from things like diet and exercise.

So before you ask your doctor for a drug, ask a better question: “Do I actually need this, or is there another way?”

Quick aside — most internet financial advice comes from people who weren’t alive during the last recession. I’ve been writing about money for more than 35 years. Want rock-solid advice? Sign up for the free Money Talks Newsletter. Takes 10 seconds. No fluff. No spam.

4. Always ask about the generic

Here’s where the ads really cost you. The drugs on TV are almost always pricey brand-name products still under patent. But a generic — or an older, cheaper drug that does the same job — often exists.

Generics can run up to 85% less than brand-name versions, according to the FDA, and they’re held to the same standards. So ask your doctor or pharmacist a simple question: Is there a cheaper version that works just as well?

It’s worth the ask. There are plenty of ways to cut your prescription costs.

5. Be extra skeptical of brand-new drugs

The newest drug isn’t automatically the best one. It’s just the one with the biggest ad budget and the most patent life left to protect.

Newer medications also have the shortest track record, which means rare side effects may not surface until millions of people have taken them. A drug that’s been around 20 years has 20 years of safety data. The one debuting during the big game doesn’t.

We’ve seen how heavy marketing can outrun the evidence — just look at the heavily advertised memory supplements that don’t actually work.

6. Don’t let a 60-second commercial run your health care

The ad wants you to walk in to your doctor’s office and ask for a drug. Fine — talk to your doctor. Just flip the script.

Tell them you saw the commercial and you want the honest version: the real benefits, the real risks, the cheaper options, and whether you need a prescription at all. Say the word “cost” out loud, and ask your pharmacy for the cash price — sometimes it beats your insurance copay.

A good doctor would rather have that conversation than watch you take something you can’t afford or don’t need.

You’re the customer here. Act like it.

These ads aren’t going to stop — not while they keep working this well, and not in one of only two countries on Earth that allow them. But you don’t have to be the target.

Watch them with your guard up, ask the questions the commercial skips, and you’ll make smarter calls for your health and your wallet. The drug companies have a multibillion-dollar plan for your attention. Now you’ve got one too.



Source link

Tags: AdsbeatdrugWaysworking
ShareTweetShare
Previous Post

Why You Keep Dreaming About Work (and Strategies to Make It Stop)

Next Post

The Data Is Lying: What Buyers Are Really Paying in 2026

Related Posts

All signs are pointing to the total and imminent collapse of the United States housing market.

All signs are pointing to the total and imminent collapse of the United States housing market.

by FeeOnlyNews.com
August 7, 2026
0

All signs are pointing to the total and imminent collapse of the United States housing market.What is about to happen...

Cities holding up to 3 million people found under Amazon rain forest

Cities holding up to 3 million people found under Amazon rain forest

by FeeOnlyNews.com
August 7, 2026
0

Archaeologists have officially discovered a massive, completely lost ancient civilization hidden deep beneath the Amazon rainforest using advanced LiDAR laser...

nLIGHT Releases Q2 2026 Financial Results

nLIGHT Releases Q2 2026 Financial Results

by FeeOnlyNews.com
August 7, 2026
0

AlphaStreet Newsdesk powered by AlphaStreet Intelligence LASR|EPS $0.15 vs $0.14 est (+7.1%)|Rev $82.6M|Net Loss $1.3M Q2 2026 non-GAAP earnings at...

The  Burrito Debate Reveals GOP’s Affordability Rift

The $20 Burrito Debate Reveals GOP’s Affordability Rift

by FeeOnlyNews.com
August 7, 2026
0

Sometimes a burrito isn’t just a burrito. What started as a complaint about a $20 burrito has turned into one...

Doximity shares double. Here’s what’s driving it 

Doximity shares double. Here’s what’s driving it 

by FeeOnlyNews.com
August 7, 2026
0

Doximity at the New York Stock Exchange for its initial public offering on June 24, 2021.Source: NYSEShares of medical platform...

E.W. Scripps Q2 2026 Loss Widens to -.68/Share, Revenue Down 9%

E.W. Scripps Q2 2026 Loss Widens to -$12.68/Share, Revenue Down 9%

by FeeOnlyNews.com
August 7, 2026
0

AlphaStreet Newsdesk powered by AlphaStreet Intelligence SSP|Loss Per Share $12.68 vs -$0.40 est (-3070.0%)|Rev $490.4M|Net Loss $1.15B Stock $2.95 (+2.8%)...

Next Post
Meta Platforms (META): Das aktuelle Gap-Up liefert ein klares Signal!

Meta Platforms (META): Das aktuelle Gap-Up liefert ein klares Signal!

Why the Advisers Act of 1940 is still worth celebrating — and protecting

Why the Advisers Act of 1940 is still worth celebrating — and protecting

  • Trending
  • Comments
  • Latest
Coffee Break: Armed Madhouse – From Spy Satellites to Peace Satellites

Coffee Break: Armed Madhouse – From Spy Satellites to Peace Satellites

July 7, 2026
US prosecutors examine LA Dodgers owner Mark Walter-linked insurers – report

US prosecutors examine LA Dodgers owner Mark Walter-linked insurers – report

July 21, 2026
Teachers’ Unions Shell Out More Than  Billion on Politics

Teachers’ Unions Shell Out More Than $1 Billion on Politics

May 14, 2026
Why did a 4 billion CEO just endorse stripping most Americans of voting rights?

Why did a $154 billion CEO just endorse stripping most Americans of voting rights?

July 27, 2026
Product-Market Fit Expires Every 90 Days. Here’s What to Do About It.

Product-Market Fit Expires Every 90 Days. Here’s What to Do About It.

July 15, 2026
Bond Vet and Small Door Merge to Form One of the Nation’s Largest Premium Veterinary Networks – AlleyWatch

Bond Vet and Small Door Merge to Form One of the Nation’s Largest Premium Veterinary Networks – AlleyWatch

July 9, 2026
Advanced Micro Devices (AMD) Price Prediction: How Much a ,000 Investment Could Be Worth by 2031

Advanced Micro Devices (AMD) Price Prediction: How Much a $5,000 Investment Could Be Worth by 2031

0
Cities holding up to 3 million people found under Amazon rain forest

Cities holding up to 3 million people found under Amazon rain forest

0
Republican Party Displacement | Mises Institute

Republican Party Displacement | Mises Institute

0
Bybit Uses Tokenised Equities as Underlyings for Structured Yield

Bybit Uses Tokenised Equities as Underlyings for Structured Yield

0
Explained: How BSE traded fewer contracts after CAS but premiums rose 75% in first week

Explained: How BSE traded fewer contracts after CAS but premiums rose 75% in first week

0
Vaxart outlines Phase IIb COVID-19 top line data in first half of 2027 backed by BARDA funding (OTCMKTS:VXRT)

Vaxart outlines Phase IIb COVID-19 top line data in first half of 2027 backed by BARDA funding (OTCMKTS:VXRT)

0
Advanced Micro Devices (AMD) Price Prediction: How Much a ,000 Investment Could Be Worth by 2031

Advanced Micro Devices (AMD) Price Prediction: How Much a $5,000 Investment Could Be Worth by 2031

August 8, 2026
Republican Party Displacement | Mises Institute

Republican Party Displacement | Mises Institute

August 8, 2026
Vanguard Chief Economist: AI and jobs, still in an ATM phase

Vanguard Chief Economist: AI and jobs, still in an ATM phase

August 8, 2026
Explained: How BSE traded fewer contracts after CAS but premiums rose 75% in first week

Explained: How BSE traded fewer contracts after CAS but premiums rose 75% in first week

August 8, 2026
Democrats’ Affordability Message Misses a Key Expense—Student Debt

Democrats’ Affordability Message Misses a Key Expense—Student Debt

August 8, 2026
Banks or NBFCs? DSP’s Preethi R S explains where she sees the best opportunities

Banks or NBFCs? DSP’s Preethi R S explains where she sees the best opportunities

August 8, 2026
FeeOnlyNews.com

Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.

CATEGORIES

  • Business
  • Cryptocurrency
  • Economy
  • Financial Planning
  • Investing
  • Market Analysis
  • Markets
  • Money
  • Personal Finance
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Advanced Micro Devices (AMD) Price Prediction: How Much a $5,000 Investment Could Be Worth by 2031
  • Republican Party Displacement | Mises Institute
  • Vanguard Chief Economist: AI and jobs, still in an ATM phase
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclaimers
  • About Us
  • Contact Us

Copyright © 2022-2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Sign In with Facebook
Sign In with Google
Sign In with Linked In
OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Business
  • Financial Planning
  • Personal Finance
  • Investing
  • Money
  • Economy
  • Markets
  • Stocks
  • Trading

Copyright © 2022-2024 All Rights Reserved
See articles for original source and related links to external sites.